Birmingham, West Midlands -- (SBWIRE) -- 12/24/2013 -- Value Penny Stocks issues special report on Sigma Labs Inc (OTCMKTS:SGLB), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), OncoSec Medical Inc (OTCMKTS:ONCS).
Sigma Labs Inc (OTCMKTS:SGLB) ended its recent business day with the gain of 2.47% and closed at the price of $0.17 after opening at $0.17. The stock traded during its last trading session with the total volume of 21.90 million shares, as compared to its average volume of 7.63 million shares. Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and R&D solutions. It also focuses on commercializing technologies and products in various industry sectors, such as in process quality assurance for manufacturing.
For How Long SGLB will Fight for Profitability? Read This Trend Analysis report
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) remained among the day advancers and traded with volume of 1.37 million shares in the last session, as compared to average volume of 529,869.00 shares. In comparison with 52 week range of $50.19 - $70.52, it faced lowest price of $68.06 during the last trading session whereas its day highest price was $68.60. The company’s total market capitalization is $236.17 billion, along with 3.45 million shares outstanding. Roche Holding AG operates in the pharmaceuticals and diagnostics businesses in Switzerland, European Union, and internationally. It discovers, develops, and delivers diagnostic and therapeutic products and services that enable patients and healthcare professionals in the detection, prevention, diagnosis, treatment, and treatment monitoring of diseases.
For How Long RHHBY’s Gloss will Attract Investors? Find out via this report
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) showed 2.62 million shares in volume during the last trading session, while the average trading volume remained 1.02 million shares. The stock kicked off its trading session at $1.52 and closed at $1.84 after mounting 22.67%. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications. The company’s product line includes PV-10, a Phase II study completed drug candidate for metastatic melanoma, a Phase I study completed candidate for breast cancer, and a Phase I protocol expansion candidate for liver metastasis.
Will PVCT Continue To Move Higher? Find Out Here
OncoSec Medical Inc (OTCMKTS:ONCS) stock traded during its last trading session with the total traded volume of 6.16 million shares versus its average volume of 1.80 million shares. The company opened its trade at the price of $0.45 and its closing price was $0.475 after gaining 5.67% for the day. OncoSec Medical Incorporated, a drug-medical device and therapeutic company, designs, develops, and commercializes medical approaches for the treatment of solid tumors in the United States. The company is developing technology based on the proprietary use of an electroporation platform to enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse).
Why Should Investors Buy ONCS After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)